LPA and myeloid sarcoma: When analyzing the behavior of the serum Lp(a) concentration according to presence of MS, individuals with the diagnosis appeared to have higher levels than those without the diagnosis (with MS: 29.16 ± 13.19 versus without MS: 26.09 ± 11.84 mg/dL; P = 1.19 × 10−6).